O	0	10	Inhibition	Inhibition	NN	B-NP
O	11	13	of	of	IN	B-PP
O	14	20	energy	energy	NN	B-NP
O	20	21	-	-	HYPH	O
O	21	30	producing	produce	VBG	B-VP
O	31	39	pathways	pathway	NNS	B-NP
O	40	42	of	of	IN	B-PP
B-Cell	43	48	HepG2	HepG2	NN	B-NP
I-Cell	49	54	cells	cell	NNS	I-NP
O	55	57	by	by	IN	B-PP
O	58	59	3	3	CD	B-NP
O	59	60	-	-	HYPH	I-NP
O	60	73	bromopyruvate	bromopyruvate	NN	I-NP
O	73	74	.	.	.	O

O	75	76	3	3	CD	B-NP
O	76	77	-	-	HYPH	I-NP
O	77	81	BrPA	BrPA	NN	I-NP
O	82	83	(	(	(	O
O	83	84	3	3	CD	B-NP
O	84	85	-	-	HYPH	I-NP
O	85	98	bromopyruvate	bromopyruvate	NN	I-NP
O	98	99	)	)	)	O
O	100	102	is	be	VBZ	B-VP
O	103	105	an	an	DT	B-NP
O	106	116	alkylating	alkylate	VBG	I-NP
O	117	122	agent	agent	NN	I-NP
O	123	127	with	with	IN	B-PP
O	128	132	anti	anti	AFX	B-NP
O	132	133	-	-	HYPH	I-NP
B-Cancer	133	140	tumoral	tumoral	JJ	I-NP
O	141	149	activity	activity	NN	I-NP
O	150	152	on	on	IN	B-PP
B-Cancer	153	167	hepatocellular	hepatocellular	JJ	B-NP
I-Cancer	168	177	carcinoma	carcinoma	NN	I-NP
O	177	178	.	.	.	O

O	179	183	This	This	DT	B-NP
O	184	192	compound	compound	NN	I-NP
O	193	201	inhibits	inhibit	VBZ	B-VP
B-Cell	202	210	cellular	cellular	JJ	B-NP
O	211	214	ATP	ATP	NN	I-NP
O	215	225	production	production	NN	I-NP
O	226	231	owing	owe	VBG	B-VP
O	232	234	to	to	TO	B-PP
O	235	238	its	its	PRP$	B-NP
O	239	245	action	action	NN	I-NP
O	246	248	on	on	IN	B-PP
O	249	259	glycolysis	glycolysis	NN	B-NP
O	260	263	and	and	CC	O
O	264	273	oxidative	oxidative	JJ	B-NP
O	274	289	phosphorylation	phosphorylation	NN	I-NP
O	289	290	;	;	:	O
O	291	298	however	however	RB	B-ADVP
O	298	299	,	,	,	O
O	300	303	the	the	DT	B-NP
O	304	312	specific	specific	JJ	I-NP
O	313	322	metabolic	metabolic	JJ	I-NP
O	323	328	steps	step	NNS	I-NP
O	329	332	and	and	CC	I-NP
O	333	343	mechanisms	mechanism	NNS	I-NP
O	344	346	of	of	IN	B-PP
O	347	348	3	3	CD	B-NP
O	348	349	-	-	HYPH	I-NP
O	349	353	BrPA	BrPA	NN	I-NP
O	354	360	action	action	NN	I-NP
O	361	363	in	in	IN	B-PP
O	364	369	human	human	JJ	B-NP
B-Cancer	370	384	hepatocellular	hepatocellular	JJ	I-NP
I-Cancer	385	395	carcinomas	carcinoma	NNS	I-NP
O	395	396	,	,	,	O
O	397	409	particularly	particularly	RB	B-ADVP
O	410	413	its	its	PRP$	B-NP
O	414	421	effects	effect	NNS	I-NP
O	422	424	on	on	IN	B-PP
B-Cellular_component	425	438	mitochondrial	mitochondrial	JJ	B-NP
O	439	449	energetics	energetic	NNS	I-NP
O	449	450	,	,	,	O
O	451	454	are	be	VBP	B-VP
O	455	461	poorly	poorly	RB	I-VP
O	462	472	understood	understand	VBN	I-VP
O	472	473	.	.	.	O

O	474	476	In	In	IN	B-PP
O	477	480	the	the	DT	B-NP
O	481	488	present	present	JJ	I-NP
O	489	494	study	study	NN	I-NP
O	495	497	it	it	PRP	B-NP
O	498	501	was	be	VBD	B-VP
O	502	507	found	find	VBN	I-VP
O	508	512	that	that	IN	B-SBAR
O	513	523	incubation	incubation	NN	B-NP
O	524	526	of	of	IN	B-PP
B-Cell	527	532	HepG2	HepG2	NN	B-NP
I-Cell	533	538	cells	cell	NNS	I-NP
O	539	543	with	with	IN	B-PP
O	544	545	a	a	DT	B-NP
O	546	549	low	low	JJ	I-NP
O	550	563	concentration	concentration	NN	I-NP
O	564	566	of	of	IN	B-PP
O	567	568	3	3	CD	B-NP
O	568	569	-	-	HYPH	I-NP
O	569	573	BrPA	BrPA	NN	I-NP
O	574	577	for	for	IN	B-PP
O	578	579	a	a	DT	B-NP
O	580	585	short	short	JJ	I-NP
O	586	592	period	period	NN	I-NP
O	593	594	(	(	(	O
O	594	597	150	150	CD	B-NP
O	598	604	microM	microM	NN	I-NP
O	605	608	for	for	IN	B-PP
O	609	611	30	30	CD	B-NP
O	612	615	min	min	NN	I-NP
O	615	616	)	)	)	O
O	617	630	significantly	significantly	RB	B-VP
O	631	639	affected	affect	VBD	I-VP
O	640	644	both	both	CC	O
O	645	655	glycolysis	glycolysis	NN	B-NP
O	656	659	and	and	CC	O
B-Cellular_component	660	673	mitochondrial	mitochondrial	JJ	B-NP
O	674	685	respiratory	respiratory	JJ	I-NP
O	686	695	functions	function	NNS	I-NP
O	695	696	.	.	.	O

O	697	700	The	The	DT	B-NP
O	701	709	activity	activity	NN	I-NP
O	710	712	of	of	IN	B-PP
B-Cellular_component	713	726	mitochondrial	mitochondrial	JJ	B-NP
O	727	737	hexokinase	hexokinase	NN	I-NP
O	738	741	was	be	VBD	B-VP
O	742	745	not	not	RB	I-VP
O	746	755	inhibited	inhibit	VBN	I-VP
O	756	758	by	by	IN	B-PP
O	759	762	150	150	CD	B-NP
O	763	769	microM	microM	NN	I-NP
O	770	771	3	3	CD	B-NP
O	771	772	-	-	HYPH	I-NP
O	772	776	BrPA	BrPA	NN	I-NP
O	776	777	,	,	,	O
O	778	781	but	but	CC	O
O	782	786	this	this	DT	B-NP
O	787	800	concentration	concentration	NN	I-NP
O	801	807	caused	cause	VBD	B-VP
O	808	812	more	more	JJR	B-NP
O	813	817	than	than	IN	I-NP
O	818	820	70	70	CD	I-NP
O	820	821	%	%	NN	I-NP
O	822	832	inhibition	inhibition	NN	I-NP
O	833	835	of	of	IN	B-PP
O	836	841	GAPDH	GAPDH	NN	B-NP
O	842	843	(	(	(	O
O	843	857	glyceraldehyde	glyceraldehyde	NN	B-NP
O	857	858	-	-	HYPH	B-NP
O	858	859	3	3	CD	I-NP
O	859	860	-	-	HYPH	I-NP
O	860	869	phosphate	phosphate	NN	I-NP
O	870	883	dehydrogenase	dehydrogenase	NN	I-NP
O	883	884	)	)	)	O
O	885	888	and	and	CC	O
O	889	890	3	3	CD	B-NP
O	890	891	-	-	HYPH	I-NP
O	891	907	phosphoglycerate	phosphoglycerate	NN	I-NP
O	908	914	kinase	kinase	NN	I-NP
O	915	925	activities	activity	NNS	I-NP
O	925	926	.	.	.	O

O	927	939	Additionally	Additionally	RB	B-ADVP
O	939	940	,	,	,	O
O	941	942	3	3	CD	B-NP
O	942	943	-	-	HYPH	I-NP
O	943	947	BrPA	BrPA	NN	I-NP
O	948	957	treatment	treatment	NN	I-NP
O	958	971	significantly	significantly	RB	B-ADVP
O	972	980	impaired	impair	VBD	B-VP
O	981	988	lactate	lactate	NN	B-NP
O	989	999	production	production	NN	I-NP
O	1000	1002	by	by	IN	B-PP
B-Cell	1003	1008	HepG2	HepG2	NN	B-NP
I-Cell	1009	1014	cells	cell	NNS	I-NP
O	1014	1015	,	,	,	O
O	1016	1020	even	even	RB	B-ADVP
O	1021	1025	when	when	WRB	I-ADVP
O	1026	1033	glucose	glucose	NN	B-NP
O	1034	1037	was	be	VBD	B-VP
O	1038	1047	withdrawn	withdraw	VBN	I-VP
O	1048	1052	from	from	IN	B-PP
O	1053	1056	the	the	DT	B-NP
O	1057	1067	incubation	incubation	NN	I-NP
O	1068	1074	medium	medium	NN	I-NP
O	1074	1075	.	.	.	O

O	1076	1082	Oxygen	Oxygen	NN	B-NP
O	1083	1094	consumption	consumption	NN	I-NP
O	1095	1097	of	of	IN	B-PP
B-Cell	1098	1103	HepG2	HepG2	NN	B-NP
I-Cell	1104	1109	cells	cell	NNS	I-NP
O	1110	1119	supported	support	VBN	B-VP
O	1120	1122	by	by	IN	B-PP
O	1123	1129	either	either	CC	O
O	1130	1138	pyruvate	pyruvate	NN	B-NP
O	1138	1139	/	/	SYM	B-NP
O	1139	1145	malate	malate	NN	B-NP
O	1146	1148	or	or	CC	I-NP
O	1149	1158	succinate	succinate	NN	I-NP
O	1159	1162	was	be	VBD	B-VP
O	1163	1172	inhibited	inhibit	VBN	I-VP
O	1173	1177	when	when	WRB	B-ADVP
B-Cell	1178	1183	cells	cell	NNS	B-NP
O	1184	1188	were	be	VBD	B-VP
O	1189	1192	pre	pre	AFX	B-ADJP
O	1192	1193	-	-	HYPH	B-NP
O	1193	1202	incubated	incubate	VBN	B-VP
O	1203	1207	with	with	IN	B-PP
O	1208	1209	3	3	CD	B-NP
O	1209	1210	-	-	HYPH	I-NP
O	1210	1214	BrPA	BrPA	NN	I-NP
O	1215	1217	in	in	IN	B-PP
O	1218	1225	glucose	glucose	NN	B-NP
O	1225	1226	-	-	HYPH	B-NP
O	1226	1230	free	free	JJ	I-NP
O	1231	1237	medium	medium	NN	I-NP
O	1237	1238	.	.	.	O

O	1239	1241	On	On	IN	B-PP
O	1242	1245	the	the	DT	B-NP
O	1246	1251	other	other	JJ	I-NP
O	1252	1256	hand	hand	NN	I-NP
O	1256	1257	,	,	,	O
O	1258	1262	when	when	WRB	B-ADVP
B-Cell	1263	1268	cells	cell	NNS	B-NP
O	1269	1273	were	be	VBD	B-VP
O	1274	1277	pre	pre	AFX	B-ADJP
O	1277	1278	-	-	HYPH	B-NP
O	1278	1287	incubated	incubate	VBN	B-VP
O	1288	1290	in	in	IN	B-PP
O	1291	1298	glucose	glucose	NN	B-NP
O	1298	1299	-	-	HYPH	B-NP
O	1299	1311	supplemented	supplement	VBN	I-NP
O	1312	1318	medium	medium	NN	I-NP
O	1318	1319	,	,	,	O
O	1320	1326	oxygen	oxygen	NN	B-NP
O	1327	1338	consumption	consumption	NN	I-NP
O	1339	1342	was	be	VBD	B-VP
O	1343	1351	affected	affect	VBN	I-VP
O	1352	1356	only	only	RB	B-ADVP
O	1357	1361	when	when	WRB	I-ADVP
O	1362	1371	succinate	succinate	NN	B-NP
O	1372	1375	was	be	VBD	B-VP
O	1376	1380	used	use	VBN	I-VP
O	1381	1383	as	as	IN	B-PP
O	1384	1387	the	the	DT	B-NP
O	1388	1398	oxidizable	oxidizable	JJ	I-NP
O	1399	1408	substrate	substrate	NN	I-NP
O	1408	1409	.	.	.	O

O	1410	1412	An	An	DT	B-NP
O	1413	1421	increase	increase	NN	I-NP
O	1422	1424	in	in	IN	B-PP
O	1425	1435	oligomycin	oligomycin	NN	B-NP
O	1435	1436	-	-	HYPH	B-NP
O	1436	1447	independent	independent	JJ	I-NP
O	1448	1459	respiration	respiration	NN	I-NP
O	1460	1463	was	be	VBD	B-VP
O	1464	1472	observed	observe	VBN	I-VP
O	1473	1475	in	in	IN	B-PP
B-Cell	1476	1481	HepG2	HepG2	NN	B-NP
I-Cell	1482	1487	cells	cell	NNS	I-NP
O	1488	1495	treated	treat	VBN	B-VP
O	1496	1500	with	with	IN	B-PP
O	1501	1502	3	3	CD	B-NP
O	1502	1503	-	-	HYPH	I-NP
O	1503	1507	BrPA	BrPA	NN	I-NP
O	1508	1512	only	only	RB	B-ADVP
O	1513	1517	when	when	WRB	I-ADVP
O	1518	1527	incubated	incubate	VBN	B-VP
O	1528	1530	in	in	IN	B-PP
O	1531	1538	glucose	glucose	NN	B-NP
O	1538	1539	-	-	HYPH	B-NP
O	1539	1551	supplemented	supplement	VBN	I-NP
O	1552	1558	medium	medium	NN	I-NP
O	1558	1559	,	,	,	O
O	1560	1570	indicating	indicate	VBG	B-VP
O	1571	1575	that	that	IN	B-SBAR
O	1576	1577	3	3	CD	B-NP
O	1577	1578	-	-	HYPH	I-NP
O	1578	1582	BrPA	BrPA	NN	I-NP
O	1583	1590	induces	induce	VBZ	B-VP
B-Cellular_component	1591	1604	mitochondrial	mitochondrial	JJ	B-NP
O	1605	1611	proton	proton	NN	I-NP
O	1612	1619	leakage	leakage	NN	I-NP
O	1620	1622	as	as	RB	B-CONJP
O	1623	1627	well	well	RB	I-CONJP
O	1628	1630	as	as	IN	I-CONJP
O	1631	1639	blocking	block	VBG	B-VP
O	1640	1643	the	the	DT	B-NP
O	1644	1652	electron	electron	NN	I-NP
O	1653	1662	transport	transport	NN	I-NP
O	1663	1669	system	system	NN	I-NP
O	1669	1670	.	.	.	O

O	1671	1674	The	The	DT	B-NP
O	1675	1683	activity	activity	NN	I-NP
O	1684	1686	of	of	IN	B-PP
O	1687	1696	succinate	succinate	NN	B-NP
O	1697	1710	dehydrogenase	dehydrogenase	NN	I-NP
O	1711	1714	was	be	VBD	B-VP
O	1715	1724	inhibited	inhibit	VBN	I-VP
O	1725	1727	by	by	IN	B-PP
O	1728	1730	70	70	CD	B-NP
O	1730	1731	%	%	NN	I-NP
O	1732	1734	by	by	IN	B-PP
O	1735	1736	3	3	CD	B-NP
O	1736	1737	-	-	HYPH	I-NP
O	1737	1741	BrPA	BrPA	NN	I-NP
O	1742	1751	treatment	treatment	NN	I-NP
O	1751	1752	.	.	.	O

O	1753	1758	These	These	DT	B-NP
O	1759	1766	results	result	NNS	I-NP
O	1767	1774	suggest	suggest	VBP	B-VP
O	1775	1779	that	that	IN	B-SBAR
O	1780	1783	the	the	DT	B-NP
O	1784	1792	combined	combined	JJ	I-NP
O	1793	1799	action	action	NN	I-NP
O	1800	1802	of	of	IN	B-PP
O	1803	1804	3	3	CD	B-NP
O	1804	1805	-	-	HYPH	I-NP
O	1805	1809	BrPA	BrPA	NN	I-NP
O	1810	1812	on	on	IN	B-PP
O	1813	1822	succinate	succinate	NN	B-NP
O	1823	1836	dehydrogenase	dehydrogenase	NN	I-NP
O	1837	1840	and	and	CC	B-PP
O	1841	1843	on	on	IN	B-PP
O	1844	1854	glycolysis	glycolysis	NN	B-NP
O	1854	1855	,	,	,	O
O	1856	1866	inhibiting	inhibit	VBG	B-VP
O	1867	1872	steps	step	NNS	B-NP
O	1873	1883	downstream	downstream	RB	B-ADVP
O	1884	1886	of	of	IN	B-PP
O	1887	1890	the	the	DT	B-NP
O	1891	1906	phosphorylation	phosphorylation	NN	I-NP
O	1907	1909	of	of	IN	B-PP
O	1910	1917	glucose	glucose	NN	B-NP
O	1917	1918	,	,	,	O
O	1919	1923	play	play	VBP	B-VP
O	1924	1926	an	an	DT	B-NP
O	1927	1936	important	important	JJ	I-NP
O	1937	1941	role	role	NN	I-NP
O	1942	1944	in	in	IN	B-PP
B-Cell	1945	1950	HepG2	HepG2	NN	B-NP
I-Cell	1951	1955	cell	cell	NN	I-NP
O	1956	1961	death	death	NN	I-NP
O	1961	1962	.	.	.	O

